Heparin Sodium 1,000 Units And Sodium Chloride 0.9%



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 41.5%
Drug Use For Unknown Indication 36.7%
Anticoagulant Therapy 6.8%
Angiogram 2.7%
Intravenous Catheter Management 2.6%
Thrombosis Prophylaxis 1.6%
Acute Myocardial Infarction 0.9%
Angina Pectoris 0.6%
Catheterisation Cardiac 0.6%
Deep Vein Thrombosis 0.6%
Myocardial Infarction 0.6%
Prophylaxis 0.6%
Pulmonary Embolism 0.6%
Transplant Rejection 0.6%
Stent Placement 0.5%
Cardiac Operation 0.4%
Coronary Artery Bypass 0.4%
Diabetes Mellitus 0.4%
Renal Failure Chronic 0.4%
Sedation 0.4%
Haemorrhage 23.5%
Heparin-induced Thrombocytopenia 15.9%
Cerebrovascular Accident 15.2%
Drug Ineffective 6.1%
Death 4.5%
Thrombocytopenia 3.8%
Thrombosis 3.8%
Thrombosis In Device 3.8%
Urticaria 3.8%
Overdose 2.3%
Pulmonary Embolism 2.3%
Unresponsive To Stimuli 2.3%
Wound Infection Bacterial 2.3%
Back Pain 1.5%
Catheter Thrombosis 1.5%
Coagulopathy 1.5%
Deep Vein Thrombosis 1.5%
Drug Chemical Incompatibility 1.5%
Haematemesis 1.5%
Hemiparesis 1.5%
Secondary
Product Used For Unknown Indication 46.8%
Drug Use For Unknown Indication 35.2%
Coronary Artery Bypass 2.7%
Catheterisation Cardiac 2.7%
Intravenous Catheter Management 1.7%
Angioplasty 1.6%
Stent Placement 1.6%
Angiogram 1.1%
Cardiac Operation 1.0%
Thrombosis Prophylaxis 0.8%
Anticoagulant Therapy 0.8%
Atrial Fibrillation 0.6%
Deep Vein Thrombosis 0.6%
Prophylaxis 0.5%
Surgery 0.4%
Haemodialysis 0.4%
Continuous Haemodiafiltration 0.4%
Pain 0.4%
Respiratory Disorder 0.4%
Pulmonary Embolism 0.4%
Vomiting 31.8%
Hypotension 10.1%
Right Ventricular Failure 10.1%
Haemorrhage 6.1%
Unresponsive To Stimuli 5.5%
Thrombocytopenia 4.2%
Urinary Tract Infection 3.6%
Heparin-induced Thrombocytopenia 2.9%
Tachycardia 2.9%
Anaemia 2.5%
Confusional State 2.5%
Thrombosis 2.3%
Wound Infection 2.3%
Retching 2.1%
Sepsis 2.1%
Staphylococcal Infection 2.1%
Pain 1.7%
Platelet Count Abnormal 1.7%
Tremor 1.7%
Urinary Tract Infection Fungal 1.7%
Concomitant
Prophylaxis 28.6%
Drug Use For Unknown Indication 14.3%
Hypercholesterolaemia 14.3%
Hypertension 14.3%
Intravenous Catheter Management 14.3%
Renal Failure 14.3%
Sepsis 100.0%